Sun Pharma stock: Results are due November 3, 2026 for Sun Pharma stock

Published on 10/21/2026 at 17:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Geojit target stands at INR 2,070. Sun Pharma stock was INR 1,745.10 on NSE, up 0.12 percent from INR 1,743.00 on October 21, 2026.

Reporting dates and targets

Sun Pharma's postal-ballot results are due by November 3, 2026.
Geojit raised its target to INR 2,070.00 from INR 1,933.00 on September 21, 2026.
Sun Pharma stock stood at INR 1,745.10 on NSE on October 21, 2026, 0.12 percent above the prior close.

Sun Pharma, INE044A01036, Illustration mit AI erstellt.

Sun Pharma (ISIN INE044A01036) has scheduled postal-ballot results for on or before November 3, 2026, according to the company's October 1 notice. The vote covers an employee stock option plan and approvals linked to financing the proposed Organon acquisition, with voting closing on October 31, 2026. On the NSE, the stock stood at INR 1,745.10 on October 21, 2026 at 3:29 p.m. IST, 0.12 percent above the prior close of INR 1,743.00.

Target remains above the share price

Geojit Investments raised its Sun Pharma target to INR 2,070.00 from INR 1,933.00 in a report dated September 21, 2026, while retaining a Buy rating, as reported by DSIJ. The target lies 18.62 percent above the October 21 NSE price.

Price position on NSE

Sun Pharma's NSE range was INR 1,583.70 to INR 2,046.90 over the 52 weeks through October 21, 2026. The share price stood 14.75 percent below the high and 10.19 percent above the low. Trading volume reached 2,316,340 shares, against an average of 1,812,960 shares for the quoted period.

Valuation and voting dates

The NSE quote carried a P/E ratio of 34.62 and a market capitalization of INR 4.2 trillion on October 21, 2026. The postal ballot closes on October 31, 2026 at 5:00 p.m. IST, and the results are due on or before November 3, 2026, according to Sun Pharmaceutical Industries.

Comparison with peers

Sun Pharma: up 0.12 percent, P/E 34.62, market capitalization INR 4.2 trillion.

Cipla (NSE, INR): down 0.76 percent, P/E 31.51, market capitalization INR 1.1 trillion.

Dr. Reddy's Laboratories (NSE, INR): up 0.16 percent, P/E 31.34, market capitalization INR 1.0 trillion.

What the vote puts on the calendar

The November timetable gives shareholders two concrete dates: voting ends October 31, 2026, and the result is due by November 3, 2026. The proposed plan allows up to 12,000,000 options and uses existing shares, so the notice describes no fresh equity issue under the scheme. The financing resolutions would also raise authorized borrowing capacity to INR 700.0 billion and the investment, loan and guarantee limit to INR 800.0 billion.

Sun Pharma stock stays near mid-range

The NSE price remains below the 52-week high while the analyst target is higher than the latest quote. The upcoming vote therefore supplies the next dated company event for investors tracking the proposed acquisition and its financing framework.